SKINVISIBLE, INC. (ticker: SKVI) is an OTC-listed pharmaceutical preparations company. DredgeCap's structured extraction of SKVI's SEC filings surfaces 41 active risk signals, including 39 late-filing signals, and 2 auditor-change signals. SKVI reported $5K in revenue and -$41.28M for the period ending 2026-03-31, with operating cash flow of -$822. Cash and equivalents stood at $2K (down 86.6% year-over-year). Total assets of $119K are exceeded by total liabilities of $10.65M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
SKVI SEC Filings
Full cached SEC EDGAR filing history for SKVI, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.